11
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Temporary Cessation of Long-Term Maintenance Treatment with Omeprazole in Patients with H2-Receptor-Antagonist-Resistant Reflux Oesophagitis

, , , &
Pages 1144-1150 | Received 27 Mar 1990, Accepted 15 May 1990, Published online: 08 Jul 2009

References

  • Fellenius E, Berglindh T, Sachs G, et al. Substituted benzimidazoles inhibit gastric secretion by blocking H+ K+ ATPase. Nature 1981; 290: 159–161
  • Londong W, Londong V, Cederberg C, Steffen H. Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release. Gastroenterology 1983; 85: 1373–1378
  • Sharma B K, Walt R P, Pounder R E, et al. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 1984; 25: 957–964
  • Mueller P, Seitz H K, Simon B, et al. Vierwochige Omeprazolegabe: einfiuss auf Saureverhalten und basale Hormonspiegel. Z Gastroenterol 1984; 22: 236–240
  • Allen J M, Adrian T E, Webster J, et al. Effect of single dose of omeprazole on the gastrointestinal peptide response to food. Hepatogastroenterol 1984; 31: 44–46
  • Lanzon-Miller S, Pounder R E, Hamilton M R, et al. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1987; 1: 239–251
  • Festen H PM, Thijs J C, Lamers C BHW, et al. Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology 1984; 87: 1030–1034
  • Ekman L, Hansson E, Havu N, et al. Toxicological studies on omeprazole. Scand J Gastroenterol 1985; 20(suppl 108)53–69
  • Soil A H. Antisecretory drugs: cellular mechanisms of action. Aliment Pharmacol Ther 1987; 1: 77–89
  • Klinkenberg-Knol E C, Meuwissen S GM. Treatment of reflux oesophagitis resistant to H2-receptor antagonists. Digestion 1989; 44(suppl 1)47–53
  • Wesdorp E, Bartelsman J, Pape K, et al. Oral cimetidine in reflux esophagitis: a double-blind, controlled trial. Gastroenterology 1978; 74: 821–824
  • Lamers C. Some aspects of the Zollinger-EUison syndrome and serum gastrin. Ph.D. thesis, University of Nijmegen, Nijmegen 1976
  • Brunner G, Creutzfeldt W, Harke U, Lamberts R. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion 1988; 39: 80–90
  • Ekman L, Hansson E, Havu N, et al. Toxicological studies on omeprazole. Scand J Gastroenterol 1985; 20(suppl 108)53–69
  • Sharma B, Axelson M, Pounder R P, et al. Acid secretory capacity and plasma gastrin concentration after administration of omeprazole to normal subjects. Aliment Pharmacol Ther 1987; 1: 67–76
  • Mohammed R, Holden R J, Hearns J B, et al. Effect of eight weeks continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion and fasting serum gastrin. Gut 1983; 24: 61–66
  • Mahachai V, Walker K, Thomson A BR. Comparison of cimetidine and ranitidine on 24-hour intragastric acidity and serum gastrin profile in patients with esophagitis. Dig Dis Sci 1985; 30: 321–328
  • Hansky J, Stern Al, Korman M G, Waugh J. Effects of long term cimetidine on serum gastrin in duodenal ulcer. Dig Dis Sci 1979; 24: 468–472
  • Lanzon-Miller S, Pounder R E, Ball S G, et al. The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects. Scand J Gastroenterol 1988; 23: 244–250

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.